Europe – Gradual roll out of EUDAMED – Q&As on practical aspects related to...

The amendment of the MDR and of the IVDR through Regulation (EU) 2024/1860 addresses three topics: 1. Regulation (EU) 2024/1860 aims to ensure a high...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Medical Devices Regulations: Routes to market and in vitro diagnostic devices

This consultation applies to medical devices in Great Britain. For guidance on the regulation of devices in Northern Ireland, see Regulation of devices in Northern...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – Experts: Notified body survey shows MDR/IVDR progress despite some snags

A recent survey shows progress in the number of applications being filed with notified bodies (NB) and certificates issued under the EU Medical Device...
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – MDCG 2023-3 Rev. 1 Questions and Answers on vigilance terms and concepts...

This document aims to clarify important terms and concepts that are outlined in Section 2 of Chapter VII of Regulation (EU) 2017/745 on medical...

Europe – Q&A Obligation to inform in case of interruption or discontinuation of supply

Introduction – Objectives of the MDR/IVDR amendment The amendment of the MDR and of the IVDR through Regulation (EU) 2024/1860 addresses three topics: 1. Regulation (EU)...

Europe – Notified body official shares recommendations for successful PMCF plans

Successful postmarket clinical follow-up plans (PMCFs) should be able to provide new information that was not previously known about a device, such as delayed...
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – MDCG 2022 – 5 Rev. 1 Guidance on borderline between medical devices...

The demarcation between the Regulation (EU) 2017/745 on medical devices (MDR) on the one hand and the Directive 2001/83/EC on the Community code relating to...

Europe – MDCG 2024-13 Regulatory status of ethylene oxide (EtO) intended for the...

The regulatory status of ethylene oxide (EtO) for the sterilisation of single-use medical devices during the manufacturing process has been discussed in relation to...
TEAM-NB : Survey on NBs applications against IVD new regulation

Europe – MDR Certification Process (including Pre-application, Application and Post Application phases) – Consensus...

The purpose of this consensus document is to describe in detail the pre-application, application processes through which manufacturers may apply to Notified Bodies (NBs)...

Europe – EMA establishes regular procedure for scientific advice on certain high-risk medical devices

EMA, in close collaboration with the European Commission, has established a standard procedure for manufacturers of certain high-risk medical devices to request scientific advice on their...

NOS PROCHAINES FORMATIONS